Zyphar's Pharmaceutics Private Limited, a active private limited company, was established on 17 February 2006 in Pune, Maharashtra, India. Engaging in drug formulation & development within the trade sector, it holds CIN: U24231PN2006PTC022042. Registered under ROC Roc Pune. it is unlisted. It has an authorized capital of ₹4.95 Cr and a paid-up capital of ₹4.95 Cr.
It upholds a compliant status. Employing 146 professional, Its leadership includes Mahendra Champalal Jain (Director), Rajeshkumar Champalal Jain (Managing Director), Roshan Champalal Jain (Director). Past directors included Rajeshkumar Champalal Jain, Sachin Ganeshmal Sonigara. It holds ₹20.75 Cr open charges and ₹6.89 Cr settled loans. Its latest AGM occurred on 30 September 2024, with the balance sheet filed on 31 March 2024. It is based at Office No. 102 & 103, Park Plaza, First Floor, Opp Kamala Nehru Park, Erandwane,, Pune, Maharashtra, 411004.
U24231PN2006PTC022042
022042
17 February 2006
₹4.95 Cr
₹4.95 Cr
Roc Pune
Unlisted
Active
Explore comprehensive insights into Zyphar's Pharmaceutics Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Mahendra Champalal Jain | Director | 17 Feb 2006 | Current |
| Rajeshkumar Champalal Jain | Managing Director | 17 Feb 2006 | Current |
| Roshan Champalal Jain | Director | 17 Feb 2006 | Current |
| Kapil Ganeshmal Sonigara | Director | 17 Feb 2006 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Director | 01 Jan 2014 | Past |
| Pramod Abcsdd | Director | 09 Jan 2020 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Zyphar'S Pharmaceutics Private Limited, for the financial year ended 2024, experienced Minor drop in revenue, with a 8.71% decrease. The company also saw a substantial improvement in profitability, with a 15.54% increase in profit. The company's net worth Soared by an impressive increase of 29.53%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2024, Zyphar'S Pharmaceutics had a promoter holding of 57.74% and a public holding of 42.26%. The company had 2 Subsidiaries. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
₹207,500,000.00
₹68,915,000.00
| Date | Lender | Amount | Status |
|---|---|---|---|
| 12 Sep 2025 | Others | ₹2.00 Cr | Open |
| 22 Oct 2019 | Others | ₹1.00 Cr | Open |
| 11 Jun 2019 | Others | ₹1.00 Cr | Open |
| 06 Feb 2018 | Others | ₹5.00 M | Open |
| 10 Jun 2016 | Others | ₹2.50 M | Open |
Explore comprehensive loan charge details -
Zyphar'S Pharmaceutics has a workforce of 146 employees as of Apr 08, 2025. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Gain comprehensive insights into the Deals and Valuation data of Zyphar'S Pharmaceutics, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Zyphar'S Pharmaceutics's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
A charge with Others amounted to Rs. 2.00 Cr with Charge ID 101161431 was registered on 12 Sep 2025. was recorded as a recent event.
The activity A charge with Others of Rs. 16.00 Cr registered on 23 Dec 2014 with Charge ID 10543756 was modified on 12 Sep 2025. was completed.
The activity A charge registered on 17 Jun 2021 via Charge ID 100486862 with Others was fully satisfied on 31 Jan 2025. was completed.
The activity A charge registered on 17 Jun 2021 via Charge ID 100464570 with Others was fully satisfied on 31 Jan 2025. was completed.
The activity Zyphar'S Pharmaceutics Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records. was completed.
The activity Zyphar'S Pharmaceutics Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Pune. was completed.
The CIN of Zyphar's Pharmaceutics Private Limited is U24231PN2006PTC022042.
Zyphar's Pharmaceutics Private Limited is headquartered at Office No. 102 & 103, Park Plaza, First Floor, Opp Kamala Nehru Park, Erandwane,, Pune, Maharashtra, 411004.
Zyphar's Pharmaceutics Private Limited was incorporated on 17 February 2006.
The current directors of Zyphar's Pharmaceutics Private Limited are
The primary industry of Zyphar's Pharmaceutics Private Limited is Trade.
Zyphar's Pharmaceutics Private Limited is unlisted.
The authorized capital of Zyphar's Pharmaceutics Private Limited is ₹4.95 Cr, and the paid-up capital is ₹4.95 Cr.
The compliance status of Zyphar's Pharmaceutics Private Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX